Activity Overview

This online, on-demand virtual symposium brings together renowned experts in early-stage and advanced breast cancer. In this educational program, these experts use real-world patient scenarios to provide practical guidance and explore clinical controversies.

This educational activity is an archive of the live symposium held on March 6, 2026.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers involved in the treatment and management of patients with breast cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Interpret ctDNA and molecular residual disease (MRD) data from clinical trials to inform patient-centered decision-making in early-stage and metastatic breast cancer
Apply evidence from ctDNA-guided studies to determine when liquid biopsy testing may appropriately inform clinical decision-making in breast cancer

Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Natera, Inc.

Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer

GET STARTED WITH THIS PROGRAM:

Related Content